CEO of Robert Schuman Hospitals Group (HRS) since 2022

​

Dr. Berna specialized in gastroenterology and internal medicine, and has a lot of experience in interventional endoscopy, biomedical research, and medical education. He is also a lecturer and academic coordinator at the University of Luxembourg.

Senior Vice President Luxembourg and France at NTT DATA

​

The global IT services leader NTT DATA has Olivier Posty leading its operations in Luxembourg. He has been working in the IT and services industry for more than 30 years, with different positions in Europe and the US. He joined NTT in1997 and has played a key role in boosting growth, innovation, and customer-oriented solutions.

Director of the University of

Luxembourg's SnT

​

Prof. Yves Le Traon has been appointed as Director of the SnT, the University of Luxembourg's research centre for ICT in January 2024. Prof. Le Traon is a professor of computer science and software engineering expert who joined the SnT in 2009 and became its Deputy Director in 2020. He has a strong record of scientific collaborations and industrial partnerships. He also knows the University, the SnT and Luxembourg well.

CEO at LNDS

​

Bert Verdonck is the CEO of LNDS, a governmental organisation that builds data spaces in the public sector, based on the Gaia-X framework. He has a background at Philips, where he worked on health data sharing and data & AI strategy. He has expertise in business, marketing, sales, product management, clinical informatics, cloud, data and AI/AR, population health, and medical image processing. He explores the adoption of the Gaia-X framework, scouting for European initiatives with a potential to scale.

General Director at eSanté

​

Ian Tewes is the General Director of Agence eSanté, Luxembourg’s national agency for the exchange and sharing of health data, both on national level and in the EU cross-border context of the MyHealth@EU services in Luxembourg. He was appointed to this position in September 2023, after serving having served as First Government Advisor and Coordinator of the Ministry of Health's "Digital Health" department. He has a strong background in health policy, digital transformation, and innovation. He is leading the implementation of the Health Information System Luxembourg (HISL) project, which aims to improve the quality and efficiency of care delivery by providing seamless access to health data for all stakeholders.

Special Advisor, Digitalisation, Data Economy and National Gaia-X Coordinator, at Luxinnovation

​

Ralf Hustadt is a Special Advisor for Digitalisation, Data Economy and is the National Gaia-X Coordinator at Luxinnovation, the national agency for innovation and research in Luxembourg. He is also the Lead of the National Competence Centre for Supercomputing, which provides high-performance computing services and support to the research and industrial communities. He is a member of the HPC Master Advisory Board at the University of Luxembourg, where he contributes to the development and promotion of the Master in High Performance Computing and Data Science. He has a long-standing experience in digital transformation, data management, and cloud computing, and he is actively involved in the Gaia-X initiative, the European project to create a federated data infrastructure that ensures data sovereignty and trust.

CEO at Luxembourg Institute of Health (LIH)

​

Ulf Nehrbass serves as CEO of LIH, the Luxembourg Institute of Health. The institute is focusing on biomedical and translational research with the aim of impacting on patients.

Ulf Nehrbass has spent his career focusing on the application of excellent research towards unmet patient needs. As the Director and founder of Institut Pasteur Korea he established one of the first translational drug discovery institutes. The project, starting in 2004, relied on target-free, visual drug discovery with live disease models. This resulted in the development of Q203, a first in class compound and the world’s most potent candidate against tuberculosis, currently in Clinical Phase II. Ulf Nehrbass was also founder and CEO of Qurient Therapeutics, which has undergone a successful I.P.O. in 2016. More recently Ulf started the French German translational center, Ksilink, which was co-founded by Sanofi, INSERM, the Helmholtz Gemeinschaft and others. Based in Strasbourg, France, Ksilink is employing Artificial intelligence approaches to enable patient-based drug discovery. Founded in 2014 Ksilink is becoming a highly successful player in this emerging field.

 

Prior to his translational engagement Ulf worked as a Chef d’Unité at the Institut Pasteur in Paris and a research associate with the Howard Hughes Medical Institute at the Rockefeller University in New York. He did his studies in Biochemistry at Cambridge University, UK and performed his thesis work with a PhD fellowship at EMBL in Heidelberg. In 2006, Ulf Nehrbass was nominated EMBO fellow.